Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic faster neurons

Molecular Psychiatry

Volumn 5, Issue 3, 2000, Pages 332-336

  Lee, D ^a   Huang, W ^a   Wang, L ^a   Copolov, D ^a   Lim, A T ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Atrial natriuretic factor producing neurons; Dopamine receptor subtypes; Glucocorticoid; Primary neuron cultures

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DEXAMETHASONE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 5 RECEPTOR; GLUCOCORTICOID; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; OXPRENOATE POTASSIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HYPOTHALAMUS; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR DOWN REGULATION; STRESS;

EID: 0033920039     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000723     Document Type: Article

References (25)

1. 1 Sanyal S, Van Tol HH. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. J Psychiatr Res 1997; 31: 219-232.
2. 2 Weinberger DR. The biological basis of schizophrenia: new directions. J Clin Psychiatry 1997; 58 Suppl 10: 22-27.
3. 3 Breier A, Wolkowitz OM, Pickar D. Stress and schizophrenia. In: Tamminga CA, Schulz SC (eds). Advances in Neuropsychiatry and Psychopharmacology, Vol 1: Schizophrenia Research. Raven Press: New York, 1991, pp 141-152.
4. 2 receptor interaction. Mol Psychiatry 2000; 5: 39-48.
5. 5 Delbende C, Delarue C, Lefebvre H, Bunel DT, Szafarczyk A, Mocaer E et al. Glucocorticoids, transmitters and stress. Br J Psychiatry Suppl 1992; 15: 24-35.
6. 6 Okubo Y, Sahara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634-636.
7. 7 Brunello N, Masotto C, Steardo L, Markstein R, Racagni G. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 1995; 13: 177-213.
8. 8 Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15: 264-270.
9. 9 Sanfilipo M, Wolkin A, Angrist B, van Kammen DP, Duncan E, Wieland S et al. Amphetamine and negative symptoms of schizophrenia. Psychopharmacol Berl 1996; 123: 211-214.
10. 10 Lee D, Dong P, Copolov DL, Lim AT. D5 dopamine receptors mediate estrogen-induced stimulation of hypothalamic ANF neurons. Mol Endocrinol 1999; 13: 344-352.
11. 11 Huang W, Choi CL, Yang Z, Copolov DL, Lim AT. Forskolin induced immunoreactive atrial natriuretic peptide secretion and pro-ANP mRNA expression of hypothalamic neurons in culture: modulation by glucocorticoids. Endocrinology 1991; 128: 2591-2600.
12. 12 Lee D, Huang W, Yang Z, Copolov DL, Lim AT. In vitro evidence for modulation of morphological and functional development of hypothalamic ir-ANP neurons by 3′5′-cyclicadenosine monophosphate. Endocrinology 1992; 131: 911-918.
13. 13 Leo D, Huang W, Copolov DL, Lim AT. D2 receptors mediate dopamine suppression of irANF release and pro-ANF mRNA expression of rat hypothalamic neurons in culture. Mol Cell Neurosci 1994; 5: 523-529.
14. 14 Arriza J, Weinberger C, Cerelli G, Glaser T, Handelin B, Housman D et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with glucocorticoid receptor. Science 1987; 237: 268-275.
15. 15 Lee D, Huang W, Copolov DL, Lim AT. Glucocorticoids inhibit D1b, but not D2, receptor-mediated effects on hypothalamic atrial natriuretic factor neurons. Endocrinology 1995; 136: 5570-5570.
16. 16 Rosenzweig A, Seidman CE. Atrial natriuretic factor and related peptide hormones. Ann Rev Biochem 1991; 60: 229-255.
17. 17 Atlas S, Maacck T. Atrial natriuretic factor. In: Windhager EE (ed). Handbook of Physiology, Renal Physiology. Oxford University Press: New York 1992, pp 1577-1673.
18. 18 Huang W, Lee D, Yang Z, Copolov DL, Lim AT. Norepinephrine stimulates immunoreactive (ir) atrial natriuretic peptide (ANP) secretion and pro-ANP mRNA expression from rat hypothalamic neurons in culture: effect of α2-adrenoceptors. Endocrinology 1992; 130: 2426-2428.
19. 19 Alonso G, Szafarczyk A, Assenmacher I. Immunoreactivity of hypothalamo-neurohypophysial neurons which secrete corticotrophinroleasing hormone (CRH) and vasopressin (Vp): immunocytochemical evidence for a correlation with their functional state in colchicine treated rats. Exp Brain Res 1986; 61: 497-505.
20. 20 Bush AI, Huang W, Copolov DL, Lim AT. Hypothalamic atrial natriuretic peptide secretion plasticity: differential modulation of α- and β-adrenoceptors. Neuroendocrinology 1990; 52: 65-69.
21. 21 Lim AT, Dean B, Copolov DL. Evidence for post-translational processing of auriculin B to atriopeptin III immediately prior to secretion by hypothalamic neurons in culture. Endocrinology 1990; 127: 2598-2600.
22. 22 Huang W, Lee D, Yang Z, Copolov DL, Lim AT. Plasticity of adrenoceptor responsiveness on irANP secretion and pro-ANP mRNA expression in hypothalamic neuron cultures: modulation by dexamethasone. Endocrinology 1992; 131: 1562-1564.
23. 23 Huang W, Lee D, Yang Z, Casley DJ, Throsby M, Copolov DL et al. Evidence for ANP(5-28) production by rat placental cytotrophoblasts. Endocrinology 1992; 131: 919-924.
24. 24 Throsby M, Lee D, Huang W, Yang Z, Copolov DL, Lim AT. Evidence for ANP(5 × 28) production by macrophages of the rat spleen: an immunochemical and non-radioactive in situ hybridization approach. Endocrinology 1991; 129: 991-1000.
25. 25 Throsby M, Yang Z, Lee D, Huang W, Copolov DL, Lim AT. Coexpression of atrial natriuretic factor and β-endorphin in a subpopulation of rat splenic macrophages: age related defferences. Endocrinology 1993; 133: 2889-2896.